| Michael James Quinn, | |
|
28035 Dorothy Dr, Suite 110, Agoura Hills, CA 91301-2672 | |
| (310) 302-7230 | |
| Not Available |
| Full Name | Michael James Quinn |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 28035 Dorothy Dr, Agoura Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063842557 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 94188 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael James Quinn, 19025 Ingomar St, Reseda, CA 91335-1718 Ph: (310) 302-7230 | Michael James Quinn, 28035 Dorothy Dr, Suite 110, Agoura Hills, CA 91301-2672 Ph: (310) 302-7230 |
News Archive
The pharmaceutical industry trade group PhRMA said Monday that the Food and Drug Administration should do a better job of explaining additional safeguards it mandates against certain drugs when it issues warnings, Reuters reports.
Recently, a team of researchers from the US performed a comprehensive recombination analysis across all medically relevant human coronaviruses, including 158,118 public seasonal hCoV, SARS-CoV-1, SARS-CoV-2, and MERS-CoV genome sequences with the help of the RDP4 software. They aimed at identifying the current and future risks of the emergence of recombinants of SARS-CoV-2
In a recent study, researchers analyzed antibody responses to the homologous Wu strain and several other SARS-CoV-2 variants after BNT162b2 vaccination.
GTx, Inc. announced today that in the Phase III clinical trial evaluating toremifene 80 mg for the reduction of fractures and treatment of other estrogen deficiency side effects in men with prostate cancer on androgen deprivation therapy (ADT), toremifene treatment demonstrated an improved benefit/risk ratio in men less than 80 years of age. The data were presented yesterday at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago.
ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, today announced it is offering the Septin 9 methylated DNA test, a new blood-based colorectal cancer screening method. While ARUP is not the first laboratory to offer this test, this new version, developed and validated independently by ARUP, is clinically proven to detect a higher proportion of colorectal cancers than Septin 9 tests developed by other companies.
› Verified 7 days ago
Cynthia Tl Edelstein, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 30101 Agoura Ct Ste 150, Agoura Hills, CA 91301 Phone: 805-433-5200 | |
Ms. Nancy Ann Nasser, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 30497 Canwood St Ste 103, Agoura Hills, CA 91301 Phone: 805-622-0026 | |
Zoe Gillis, M.A. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5539 Rainbow Crest Dr, Agoura Hills, CA 91301 Phone: 818-661-8164 | |
Lindsey Budd, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 30423 Canwood St Ste 129, Agoura Hills, CA 91301 Phone: 818-261-3676 | |
Jamshid Veria Farahyar, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 30101 Agoura Ct Ste 111, Agoura Hills, CA 91301 Phone: 415-756-1877 | |
Jill Michele Black, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 30101 Agoura Ct, Lobby 3 Suite 150, Agoura Hills, CA 91301 Phone: 805-657-2511 Fax: 805-856-2219 |